Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06596148

Improving Shingrix Vaccination Among US Veterans Receiving Immunosuppression

The goal of this wait-list control trial is to learn if having access to a new dashboard displaying information about immunosuppressed Veterans missing vaccinations for Shingrix can improve Shingrix vaccination rates at VA facilities.

The main question[s] it aims to answer is: Will vaccination rates improve more rapidly for facilities with access to the dashboard compare to facilities without access? VA facility personnel will be granted access to the dashboard and outcomes (vaccination rates) will be measured using electronic health record data.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Immunosuppresion

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

San Francisco VA

San Francisco, California, 94121, United States

About this study

Assignment of the intervention will occur at the facility level. Outcomes (vaccination) will be assessed for patients cared for at each facility.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • In order to be included in the study, clinicians need to work at a VHA facility and have access to the electronic health record.

Exclusion criteria

  • None.

Treatment and study plan

Access to Shingrix dashboard

Other

The investigators will build and grant access to a clinical dashboard that exists behind the VA firewall. The dashboard will identify Veterans from each VA facility who are receiving immunosuppressants (prescribed via the VA). The dashboard will also provide information about the number of Shingrix vaccines each patient has received (which have been documented within the VA electronic health record). VA clinicians will have access to view information about patients based on their VA electronic health record permissions.

Primary outcomes

  1. Percentage of patients with at least 1 Shingrix vaccine documented, by facility

    Time frame: From enrollment until end of follow up at 18 months.

    Percentage of patients with at least 1 Shingrix vaccinations documented, by facility

Secondary outcomes

  1. Percentage of patients with at least 2 Shingrix vaccinations documented, by facility

    Time frame: From enrollment until end of follow up at 18 months.

    Percentage of patients with at least 2 Shingrix vaccinations documented, by facility

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • San Francisco Veterans Affairs Medical Center

Registry information

Official study title

VA Quality Improvement Research and Training Initiative

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Sep 19, 2024
Registry last updated
Apr 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.